These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7825460)

  • 21. Induction of mucosal immunity through systemic immunization: Phantom or reality?
    Su F; Patel GB; Hu S; Chen W
    Hum Vaccin Immunother; 2016 Apr; 12(4):1070-9. PubMed ID: 26752023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucosal immunity in the female genital tract: relevance to vaccination efforts against the human immunodeficiency virus.
    Mestecky J; Kutteh WH; Jackson S
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S11-20. PubMed ID: 7865284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of mucosal immune responses by T lymphocytes: the effect of chronic CD4+ T cell deficiency on IgA synthesis.
    Mega J; Fujihashi K; Kiyono H
    Reg Immunol; 1992; 4(2):70-8. PubMed ID: 1354470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enteric immunization reveals a T cell network for IgA responses and suggests that humans possess a common mucosal immune system.
    McGhee JR; Kiyono H; Michalek SM; Mestecky J
    Antonie Van Leeuwenhoek; 1987; 53(6):537-43. PubMed ID: 3329827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous approach using systemic, mucosal and transcutaneous routes of immunization for development of protective HIV-1 vaccines.
    Belyakov IM; Ahlers JD
    Curr Med Chem; 2011; 18(26):3953-62. PubMed ID: 21824096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
    Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
    APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Passive and active protection against disorders of the gut.
    Mestecky J; Russell MW
    Vet Q; 1998; 20 Suppl 3():S83-7. PubMed ID: 9689734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humoral immune response patterns of human mucosae: induction and relation to bacterial respiratory tract infections.
    Brandtzaeg P
    J Infect Dis; 1992 Jun; 165 Suppl 1():S167-76. PubMed ID: 1588157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity.
    Rochereau N; Pavot V; Verrier B; Jospin F; Ensinas A; Genin C; Corthésy B; Paul S
    J Allergy Clin Immunol; 2016 Jan; 137(1):214-222.e2. PubMed ID: 26414879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanocarriers: a versatile approach for mucosal vaccine delivery.
    Mody N; Sharma R; Agrawal U; Vyas SP
    Ther Deliv; 2015 Feb; 6(2):231-45. PubMed ID: 25690089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New generation of mucosal adjuvants for the induction of protective immunity.
    Yuki Y; Kiyono H
    Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delivery strategies to enhance oral vaccination against enteric infections.
    Davitt CJ; Lavelle EC
    Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCL19 and CCL28 augment mucosal and systemic immune responses to HIV-1 gp140 by mobilizing responsive immunocytes into secondary lymph nodes and mucosal tissue.
    Hu K; Luo S; Tong L; Huang X; Jin W; Huang W; Du T; Yan Y; He S; Griffin GE; Shattock RJ; Hu Q
    J Immunol; 2013 Aug; 191(4):1935-47. PubMed ID: 23858028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New perspectives in mucosal immunity with emphasis on vaccine development.
    McGhee JR; Fujihashi K; Xu-Amano J; Jackson RJ; Elson CO; Beagley KW; Kiyono H
    Semin Hematol; 1993 Oct; 30(4 Suppl 4):3-12; discussion 13-5. PubMed ID: 8303308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal immunity: induction, dissemination, and effector functions.
    Brandtzaeg P
    Scand J Immunol; 2009 Dec; 70(6):505-15. PubMed ID: 19906191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction and molecular properties of secretory and serum IgA antibodies specific for environmental antigens.
    Mestecky J; Czerkinsky C; Russell MW; Brown TA; Prince SJ; Moldoveanu Z; Jackson S; Michalek SM; McGhee JR
    Ann Allergy; 1987 Nov; 59(5 Pt 2):54-9. PubMed ID: 3318587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human male genital tract secretions: both mucosal and systemic immune compartments contribute to the humoral immunity.
    Moldoveanu Z; Huang WQ; Kulhavy R; Pate MS; Mestecky J
    J Immunol; 2005 Sep; 175(6):4127-36. PubMed ID: 16148163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of lymphoblast traffic and localization in mucosal tissues, with emphasis on IgA.
    Bienenstock J; Befus D; McDermott M; Mirski S; Rosenthal K
    Fed Proc; 1983 Dec; 42(15):3213-7. PubMed ID: 6641955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mucosal immune system: from fundamental concepts to vaccine development.
    McGhee JR; Mestecky J; Dertzbaugh MT; Eldridge JH; Hirasawa M; Kiyono H
    Vaccine; 1992; 10(2):75-88. PubMed ID: 1539467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dry powder vaccines for mucosal administration: critical factors in manufacture and delivery.
    Wang SH; Thompson AL; Hickey AJ; Staats HF
    Curr Top Microbiol Immunol; 2012; 354():121-56. PubMed ID: 21822816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.